Key result
NaV1.5 Y1495 phosphorylation causes a ~17-mV depolarizing shift in steady-state inactivation while preserving late-current suppression.
Why the study?
Inactivation of the cardiac sodium channel Nav1.5 is modulated by both tyrosine phosphorylation and protein-protein interactions, but whether or how these two mechanisms intersect was unclear.
Does site-specific phosphorylation at Y1495 in the NaV1.5 DIII-DIV linker modulate the functional regulatory effects of intracellular fibroblast growth factor homologous factors (iFGFs) on channel steady-state inactivation and late sodium current in Xenopus laevis oocytes?
Does site-specific phosphorylation at Y1495 in the NaV1.5 DIII-DIV linker modulate the functional regulatory effects of intracellular fibroblast growth factor homologous factors (iFGFs) on channel steady-state inactivation and late sodium current in Xenopus laevis oocytes?
This study demonstrates that a single post-translational modification (phosphorylation at Y1495 on NaV1.5) does not abolish auxiliary iFGF protein binding but selectively redirects its functional output by turning off steady-state inactivation shifts while preserving anti-arrhythmic late current suppression.
Answers are grounded in this paper and cite their sources.
Y1495 phosphorylation selectively redirects iFGF effects on NaV1.5 in oocytes; hypothesis-generating for human arrhythmia mechanisms, not yet practice-changing.
The cardiac sodium channel Nav1.5 carries the upstroke of the cardiac action potential, and its inactivation needs to be precisely controlled: shifts of only a few millivolts in steady-state inactivation (SSI), or incomplete pore closure generating a late current, are arrhythmogenic. Inactivation is modulated by both tyrosine phosphorylation and protein-protein interactions, but whether or how the two intersect is unclear. Combining protein semi-synthesis with electrophysiology, biochemistry, fluorometry and molecular dynamics simulations, we control phosphorylation at Y1495 in the DIII-DIV linker and demonstrate how it governs regulation by intracellular fibroblast growth factor homologous factors (iFGFs). We find that iFGFs act through two separable mechanisms: a depolarizing SSI shift of around 16 mV that is switched off by phosphorylation, and a suppression of late current that proceeds regardless of phosphorylation. Only the former requires an intact C-terminal domain/DIII-DIV linker interaction, and both differ between iFGF isoforms. Phosphorylation at Y1495 therefore does not switch off the iFGF interaction but instead redirects its output. Together, this reveals a mode of ion channel regulation in which a single post-translational modification selects between different functional consequences of a protein-protein interaction.
No takes yet. Share an insight, caveat, or question.
Peverini et al. (2026) studied Cardiac sodium channel NaV1.5 gating and arrhythmogenesis. Tyrosine phosphorylation at Y1495 (Phos1495) of NaV1.5 and co-expression of intracellular fibroblast growth factor homologous factors (iFGFs) vs. Unphosphorylated NaV1.5 (No Phos1495) and wild-type NaV1.5 without iFGF co-expression was evaluated on Steady-state inactivation (V50SSI) shift and late sodium current suppression. Phosphorylation of NaV1.5 at Y1495 induces a ~16.5 mV depolarizing shift in steady-state inactivation that abolishes further iFGF A-isoform SSI shifts while preserving iFGF-mediated suppression of the ~3% late sodium current.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: